Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-005254
Filing Date
2025-01-22
Accepted
2025-01-22 16:16:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2431776d3_defa14a.htm DEFA14A 24960
  Complete submission text file 0001104659-25-005254.txt   25993
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37410 | Film No.: 25546166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)